Marco Donia

Name: tMarco Donia, M.D., Ph.D., Professor of Clinical Oncology Date of birth:14/06/1984 (41 years old) ORCID:\t\t0000-0003-4966-9752 Email: \tmarco.donia@regionh.dk LinkedIn:\t\thttps://www.linkedin.com/in/marcodonia/ Main Languages:\tEnglish (Fluent), Danish (Fluent, certified), Italian (mother tongue) Webpage:\t\thttps://bit.ly/tilgroup Personal Statement I am a clinical oncologist and immuno-oncology clinician-scientist at the University of Copenhagen and Copenhagen University Hospital, Herlev and Gentofte. Since 2018, I have led the Tumor-Infiltrating Lymphocyte (TIL) group at National Center for Cancer Immune Therapy (CCIT-DK), integrating translational immunology, real-world evidence and investigator-initiated clinical studies in melanoma and immune-based therapies. My work focuses on mechanisms of primary and acquired resistance and on optimizing adoptive cell therapy and checkpoint blockade in routine care, contributing to improved understanding of tumor–immune interactions an